Benazepril is an angiotensin-converting enzyme (ACE) inhibitor used for treating hypertension and heart failure. However, during the manufacturing process, impurities may be introduced. These impurities, such as diastereomers, enantiomers, and degradation products, may affect the safety and efficacy of the drug. Therefore, it is important to monitor and control the levels of these impurities in the final product. Regulatory agencies have set limits on the amounts of specific impurities that may be present in Benazepril formulations.
